Discover 775 paid clinical trials in Washington, D.C.. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 775
Pregnancy and Early Neurodevelopmental Outcomes Following In Utero Lyme Disease Exposure
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
for
Sickle Cell Disease (SCD)
Location: Washington D.C. DC, Wilmington DE, Philadelphia PA,
Sponsor: University of Rochester
Sex: All
Age: 3 - 20
Code: NCT06941389
Recruiting
A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
for
B-All, Acute Lymphoblastic Leukemia
Location: Washington D.C. DC, Bethesda MD, Boston MA, Atlanta GA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 25
Code: NCT05621291
Recruiting
A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
for
Leukemia, Juvenile Myelomonocytic, JMML, JCML,
Location: Washington D.C. DC, Baltimore MD, Philadelphia PA,
Sponsor: Therapeutic Advances in Childhood Leukemia Consortium
Sex: All
Age: 0 - 21
Code: NCT05849662
Phase 1, Phase 2, Recruiting
Measuring Analgesic Interventions
for
Pain
Location: Washington D.C. DC
Sponsor: Julia Finkel
Sex: All
Age: 7 - 21
Code: NCT03794362
Recruiting
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
Location: Washington D.C. DC, Bethesda MD, Baltimore MD
Sponsor: Children's National Research Institute
Sex: All
Age: 0 - 70+
Code: NCT04691622
Phase 1, Recruiting
Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.
for
Juvenile Idiopathic Arthritis
Location: Washington D.C. DC, Valhalla NY, Cincinnati OH,
Sponsor: AbbVie
Sex: All
Age: 1 - 17
Code: NCT05609630
Phase 3, Recruiting
Feasibility and Efficacy of Attentional-Control Training in Sickle Cell Disease